Helus Pharma Files Interim Financial Statements for September 30, 2026
at www.tipranks.com (Fri, 13-Nov 5:02 PM)
Cybin GAAP EPS of -$1.41 misses by $0.68
at seekingalpha.com (Fri, 13-Nov 4:48 PM)
U.S. funding to support studies into psychedelic drug ibogaine in PTSD
at seekingalpha.com (Thu, 12-Nov 12:47 PM)
DEA looks to increase legal psychedelics production for medical research
at seekingalpha.com (Tue, 10-Nov 10:45 AM)
J&J gets into psychedelic treatments with backing of Delix Therapeutics
at seekingalpha.com (Mon, 9-Nov 12:12 PM)
Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Helus Pharma (HELP)
at www.tipranks.com (Mon, 9-Nov 11:20 AM)
Market Chameleon (Tue, 3-Nov 9:13 AM)
Helus Pharma Shareholders Back Name Change With 99.32% Support, Effective Oct. 1
Market Chameleon (Wed, 23-Sep 8:39 AM)
Helus Pharma spotlights four Psych Congress 2026 posters as Phase 3 PARADIGM advances HLP003 in MDD
Market Chameleon (Mon, 21-Sep 11:13 AM)
Market Chameleon (Mon, 21-Sep 7:33 AM)
Helus Pharma Advances Late-Stage Trials and Strengthens Cash Position Amid Key Leadership Changes
Market Chameleon (Fri, 14-Aug 8:53 AM)
